CEPI begins first human trial of Bundibugyo Ebola vaccine
Add us on Google The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the start of the world’s first human clinical trial of a vaccine developed specifically against the Bundibugyo strain of the Ebola virus, with the first volunteer vaccinated at the University of Oxford. Join the Premium Times WhatsApp Community For Quick Access To News and Happenings Around You. Open in WhatsApp The announcement was contained in a statement made available to the News Agency of Nigeria (NAN) on Friday by CEPI’s Senior Communications and Advocacy Manager, Jodie Rogers.
- ▪Add us on Google The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the start of the world’s first human clinical trial of a vaccine developed specifically against the Bundibugyo strain of the Ebola virus, with the fir
- ▪Join the Premium Times WhatsApp Community For Quick Access To News and Happenings Around You.
- ▪Open in WhatsApp The announcement was contained in a statement made available to the News Agency of Nigeria (NAN) on Friday by CEPI’s Senior Communications and Advocacy Manager, Jodie Rogers.
Premium Times publishes from Nigeria and files mainly under world. We currently carry 145 of its stories.
Opening excerpt (first ~120 words) tap to expand
Add us on Google The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the start of the world’s first human clinical trial of a vaccine developed specifically against the Bundibugyo strain of the Ebola virus, with the first volunteer vaccinated at the University of Oxford. Join the Premium Times WhatsApp Community For Quick Access To News and Happenings Around You. Open in WhatsApp The announcement was contained in a statement made available to the News Agency of Nigeria (NAN) on Friday by CEPI’s Senior Communications and Advocacy Manager, Jodie Rogers. The Phase I clinical trial, known as BD-Ebov, will evaluate the safety of the experimental vaccine and its ability to stimulate immune responses in healthy adult volunteers.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Premium Times.
Discussion
0 commentsMore from Premium Times
